Skip to main content
Fig. 7 | Human Genomics

Fig. 7

From: Developing neural network diagnostic models and potential drugs based on novel identified immune-related biomarkers for celiac disease

Fig. 7

3D (left) and 2D (right) views of the interacted interface between HIGs and their top two potential binding drugs. A–C The structure of the complex formed by the docking of Tetradioxin with CCL25, MR1 and TNFSF13B. D The structure of the complexes formed by the docking of CROTONALDEHYDE with CCL25. E The structure of the complex formed by the docking of DMBA with MR1. F The structure of the complex formed by the docking of FENRETINIDE with TNFSF13B. The indicated drugs were selected according to the absolute values of the binding energy to CCL25, MR1 and TNFSF13B

Back to article page

Human Genomics

ISSN: 1479-7364